Long-term evaluation of lipid profile and oral glucose tolerance test in Norplant® users

被引：1
|
作者：
Araujo, FF [1 ]
de Lima, GR [1 ]
Guazzelli, CAF [1 ]
Barbieri, M [1 ]
Vigorito, NM [1 ]
Lindsey, PC [1 ]
Baracat, EC [1 ]
机构：
[1] Univ Fed Sao Paulo, Dept Obstet & Gynecol, Escola Paulista Med, Sao Paulo, Brazil
来源：
CONTRACEPTION | 2006年 / 73卷 / 04期
关键词：
levonorgestrel; subdermal contraceptive; Norplant (R); cholesterol; lipids; OGTT; diabetes;
D O I：
10.1016/j.contraception.2005.10.018
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Purpose: This Study reports the results of the lipid profile and oral glucose tolerance test (OGTT) in 46 normal patients tested before and after 5 years of Norplant use. Results: After 5 years, there was a Substantial decrease of 28.9% in high-density lipoprotein cholesterol levels and a similar but less pronounced fall of 7.1% in the total cholesterol levels. The Castelli 1 index did not vary, and the triglycerides and low-density lipoprotein cholesterol levels remained normal and unchanged throughout the study period. All the mean values of OGTT were significantly lower after 5 years, except for the 90-min glycemia. Conclusion: These findings indicate that long-term Norplant use does not increase cardiovascular risks. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码：361 / 363
页数：3
相关论文
共 50 条
  • [1] CHANGES OF ORAL GLUCOSE TOLERANCE TEST DURING LONG-TERM TREATMENT WITH NEUROLEPTICS
    AMDISEN, A
    ACTA PSYCHIATRICA SCANDINAVICA, 1968, S : 95 - &
  • [2] ORAL GLUCOSE-TOLERANCE TEST IN SCHIZOPHRENICS UNDER LONG-TERM NEUROLEPTIC TREATMENT
    GONCALVES, N
    GRUNEBERG, F
    PHARMAKOPSYCHIATRIE NEURO-PSYCHOPHARMAKOLOGIE, 1975, 8 (05): : 289 - 295
  • [3] Evaluation of lipid profile in adolescents during long-term use of combined oral hormonal contraceptives
    Guazzelli, CAF
    Lindsey, PC
    de Araújo, FF
    Barbieri, M
    Petta, CA
    Aldrighi, JM
    CONTRACEPTION, 2005, 71 (02) : 118 - 121
  • [4] EVALUATION OF THE PROFILE OF BLOOD GLUCOSE USING CGM IN THE POPULATION WITH NORMAL ORAL GLUCOSE TOLERANCE TEST
    Sofizadeh, S.
    Pehrsson, A.
    Olafsdottir, A.
    Pivodic, A.
    Lind, M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A219 - A219
  • [5] Long-Term Evaluation of Lipid Profile Changes in Olympic Athletes
    Di Gioia, Giuseppe
    Buzzelli, Lorenzo
    Maestrini, Viviana
    Squeo, Maria Rosaria
    Lemme, Erika
    Monosilio, Sara
    Serdoz, Andrea
    Fiore, Roberto
    Zampaglione, Domenico
    Segreti, Andrea
    Pelliccia, Antonio
    INTERNATIONAL JOURNAL OF SPORT NUTRITION AND EXERCISE METABOLISM, 2024, 34 (05) : 267 - 274
  • [6] GLUCOSE, INSULIN, AND GROWTH HORMONE STUDIES IN LONG-TERM USERS OF ORAL CONTRACEPTIVES
    SPELLACY, WN
    BUHI, WC
    SPELLACY, CE
    MOSES, LE
    GOLDZIEHER, JW
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1970, 106 (02) : 173 - +
  • [7] STANDARDIZATION AND EVALUATION OF ORAL GLUCOSE TOLERANCE TEST
    CARTER, NG
    MAYNARD, JH
    MEDICAL JOURNAL OF AUSTRALIA, 1970, 1 (26) : 1293 - +
  • [8] Serum Progranulin Concentrations are not Responsive During Oral Lipid Tolerance Test and Oral Glucose Tolerance Test
    Schmid, A.
    Leszczak, S.
    Ober, I.
    Schaeffler, A.
    Karrasch, T.
    HORMONE AND METABOLIC RESEARCH, 2015, 47 (08) : 571 - 576
  • [9] EFFECTS OF LONG-TERM THERAPY WITH ORAL HYPOGLYCEMIC AGENTS ON ORAL GLUCOSE-TOLERANCE TEST DYNAMICS IN MALE CHEMICAL DIABETICS
    TAN, MH
    GRAHAM, CA
    BRADLEY, RF
    GLEASON, RE
    SOELDNER, JS
    DIABETES, 1977, 26 (06) : 561 - 570
  • [10] Predicting long-term type 2 diabetes with support vector machine using oral glucose tolerance test
    Abbas, Hasan T.
    Alic, Lejla
    Erraguntla, Madhav
    Ji, Jim X.
    Abdul-Ghani, Muhammad
    Abbasi, Qammer H.
    Qaraqe, Marwa K.
    PLOS ONE, 2019, 14 (12):
12345